Clinical Trial Update: Zelquistinel in the Treatment of Adults With Major Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting Phase 1/2 results for Zelquistinel in adults with Major Depressive Disorder; the study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Zelquistinel (Zelquistinel)

Snippet

Sponsor: Syndeio Biosciences, Inc | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-07